Criterios para el uso terapéutico de los componentes sanguíneos
Sánchez Girón, Francisco.
Rev. mex. patol. clín
; 41(3): 84-9, jul.-sept. 1994.
Artículo en Español | LILACS | ID: lil-141547
Documentos relacionados
Conditions for plasma processing.
[The new hemotherapy guideline].
The administration of blood components: a British Society for Haematology Guideline.
Short-term deviations in temperature during storage of plasma at -40°C do not affect its quality.
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.
Statistical control of the production of blood components by control charts of attribute to improve quality characteristics and to comply with current specifications.
Advances in transfusion medicine: gastrointestinal bleeding.
[Minimum requirements for the microbiological control of blood components for transfusion. Update of the vote 16].
Reduction in plasma transfusion after enforcement of transfusion guidelines.
Appropriateness of blood product transfusion in the Obstetrics and Gynaecology (O&G) department of a tertiary hospital in West Africa.